Trial Profile
Ofatumumab Added to Dexamethasone in Subjects With Relapsed or Refractory Chronic Lymphocytic Leukemia.
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 08 Nov 2021
Price :
$35
*
At a glance
- Drugs Ofatumumab (Primary) ; Dexamethasone
- Indications Chronic lymphocytic leukaemia
- Focus Therapeutic Use
- 01 May 2015 Results published in the American Journal of Hematology.
- 03 May 2011 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
- 15 Mar 2011 New trial record